the buildings where it has operated since relocating ... glass towers that today has become an extension of downtown Boston.

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

Good morning, Boston. Here are the five things you need to know in local business news to start your Friday, including Vertex's new drug ... to convert Atlantic Ave. building Ryan also reports ...

Like other drug companies, Boston-based Vertex has a program that helps patients with insurance reduce their out-of-pocket costs for treatments. A UnitedHealth representative had no immediate comment.

While the building blocks of science and company ... after winning FDA approval of its Journavx treatment for acute pain, Boston’s Vertex is flying high even as other homegrown biotechs struggle.